Arrail Group Ltd
Arrail Group Ltd is a biotechnology company that provides healthcare facilities and services, primarily generating revenue through its operations in the healthcare sector.
Business. Arrail Group Ltd (6639.HK) is a healthcare services and equipment company primarily engaged in biotechnology activities. The firm operates within the Healthcare Facilities & Services industry, generating revenue through service-based models. Headquartered in Hong Kong, the company is listed on the Hong Kong Stock Exchange. Specific operating segments and geographic breakdowns are not disclosed in the available data.
Analyst recommendations
1 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Arrail Group Ltd (6639.HK) is a healthcare services and equipment company primarily engaged in biotechnology activities. The firm operates within the Healthcare Facilities & Services industry, generating revenue through service-based models. Headquartered in Hong Kong, the company is listed on the Hong Kong Stock Exchange. Specific operating segments and geographic breakdowns are not disclosed in the available data.
Arrail Group Ltd has a market capitalization of CNY 1.03 billion, with a current market price of CNY 1.83 per share. The company has no dilution risk, as the number of basic and diluted shares outstanding is identical at 562,095,450. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.
Profitability and return metrics are not available for Arrail Group Ltd, as the valuation snapshot does not include key financial ratios such as ROIC or margins. Analysts have provided a mean price target of CNY 3.18, with a median and high target also at CNY 3.18, indicating a consensus on the stock's potential upside. The mean recommendation score is 2.00, suggesting a generally positive outlook, although no strong buy ratings have been issued.
The company's revenue concentration and geographic exposure are not disclosed in the available data. There is no information on specific segments or geographic regions contributing to revenue, which limits the ability to assess diversification risk.
Growth trajectory is not quantified in the available data, as no revenue history or outlook numeric deltas are provided. Analysts have not issued any growth-related guidance, and the company's future performance remains speculative.
Risk factors include the inability to assess liquidity risk due to missing balance-sheet data. No dilution risk is currently present, as the number of basic and diluted shares is the same. However, the absence of going-concern language in source documents raises concerns about the company's financial health.
Recent events, including filings and transcripts, are not disclosed in the available data. There is no information on recent corporate actions, earnings calls, or regulatory updates that could impact the company's valuation or operations.
- Analysts have issued a consensus price target of CNY 3.18, indicating a potential upside from the current market price of CNY 1.83.
- The company has no dilution risk, as the number of basic and diluted shares is identical.
- Liquidity risk could not be assessed due to missing balance-sheet data and no going-concern language in source documents.
- No revenue concentration or geographic exposure data is available, limiting the ability to assess diversification risk.
- Growth trajectory and future performance remain speculative due to the absence of revenue history and outlook numeric deltas.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Revenue ¥1.75B, +18,5% YoY; Operating income +113,7% YoY.
- ▍Revenue ¥1.75B, +18,5% YoY
- ▍Operating income +113,7% YoY
- ▍Net income +107,8% YoY
- ▍Free cash flow +340,5% YoY
- ▍Net margin 1.0%
Revenue ¥1.47B, −9,2% YoY; Operating income −566,0% YoY.
- ▍Revenue ¥1.47B, −9,2% YoY
- ▍Operating income −566,0% YoY
- ▍Net income +68,6% YoY
- ▍Free cash flow +86,9% YoY
- ▍Net margin -14.9%
Revenue ¥1.62B, +7,2% YoY; Operating income +60,5% YoY.
- ▍Revenue ¥1.62B, +7,2% YoY
- ▍Operating income +60,5% YoY
- ▍Net income −16,9% YoY
- ▍Free cash flow −43,2% YoY
- ▍Net margin -43.2%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Arrail Group Ltd Market data — financials · 2026-05-27
- Arrail Group Ltd Market data — analyst estimates · 2026-05-27